Is this the smartwatch that’s affordable and functional?

If you’ve been looking to purchase a smartwatch but have been put off by some of the exorbitant prices then this new product might be what you’re looking for.

The FitOn smartwatch is labelled as the world’s first and most affordable blood oxygen saturation smartwatch, though it features of other tracking features to help keep you fit. With a starting price of less than $50, FitOn is certainly more affordable than some of the other big brands currently selling smartwatches.

The team behind FitOn is marketing the product as a smartwatch, a fitness tracker and a personal health guide. It includes all the expected features of a fitness tracker, including being able to track oxygen saturation, heart rate variability, respiratory rate, sleep quality, calories burned, stress levels and more.

FitOn also features smart workout tracking that wearers can use to analyse their exercises. The device automatically tracks running and also provides route suggestions by being connected to GPS.

More so, the FitOn app is able to sync with both android and iOS devices and integrates with Google Fit and Apple Health. FitOn connects to users’ phones via Bluetooth, letting them read texts, ignore calls and even find their phone if they misplace it. Users can also snap pictures using the FitOn and share them with other wearers of the device.

Like other wearables FitOn is water resistant to 50 meters, though the developers state that it should not be used for activities involving high-velocity water or submersion below a shallow depth.

And whilst FitOn’s developers say that the watch is able to be 99% accurate there’s no information as to how the product measures health metrics.

FitOn has already surpassed its $10,000 goal on Kickstarter and is expected to launch this December.

 



'Is this the smartwatch that’s affordable and functional?' has no comments

Be the first to comment this post!

Would you like to share your thoughts?

Your email address will not be published.

© 2018 Rapid Life Sciences Ltd, a Rapid News Communications Group Company. All Rights Reserved.

Privacy policy

Terms and conditions